...
首页> 外文期刊>Liver international : >Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
【24h】

Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.

机译:急性甲型肝炎和戊型肝炎病毒性肝炎对肝硬化的临床特征和预后指标。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND AND OBJECTIVES: Acute hepatitis A and E are recognized triggers of hepatic decompensation in patients with cirrhosis, particularly from the Indian subcontinent. However, the resulting acute-on-chronic liver failure (ACLF) has not been well characterized and no large studies are available. Our study aimed to evaluate the clinical profile and predictors of 3-month mortality in patients with this distinctive form of liver failure. METHODS: ACLF was diagnosed in patients with acute hepatitis A or E [abrupt rise in serum bilirubin and/or alanine aminotransferase with positive immunoglobulin M anti-hepatitis A virus (HAV)/anti-hepatitis E virus (HEV)] presenting with clinical evidence of liver failure (significant ascites and/or hepatic encephalopathy) and clinical, biochemical, endoscopic (oesophageal varices at least grade II in size), ultrasonographical (presence of nodular irregular liver with porto-systemic collaterals) or histological evidence of cirrhosis. Clinical and laboratory profile were evaluated, predictors of 3-month mortality were determined using univariate and multivariate logistic regression and a prognostic model was constructed. Receiver-operating curves were plotted to measure performance of the present prognostic model, model for end-stage liver disease (MELD) score and Child-Turcotte-Pugh (CTP) score. RESULTS: ACLF occurred in 121 (3.75%) of 3220 patients (mean age 36.3+/-18.0 years; M:F 85:36) with liver cirrhosis admitted from January 2000 to June 2006. It was due to HEV in 80 (61.1%), HAV in 33 (27.2%) and both in 8 (6.1%). The underlying liver cirrhosis was due to HBV (37), alcohol (17), Wilson's disease (8), HCV (5), autoimmune (6), Budd-Chiari syndrome (2), haemochromatosis (2) and was cryptogenic in the rest (42). Common presentations were jaundice (100%), ascites (78%) and hepatic encephalopathy (55%). Mean (SD) CTP score was 11.4+/-1.6 and mean MELD score was 28.6+/-9.06. Three-month mortality was 54 (44.6%). Complications seen were sepsis in 42 (31.8%), renal failure in 45 (34%), spontaneous bacterial peritonitis in 27 (20.5%), UGI bleeding in 15(11%) and hyponatraemia in 50 (41.3%). On univariate analysis, ascites, hepatic encephalopathy, renal failure, GI bleeding, total bilirubin, hyponatraemia and coagulopathy were significant predictors of mortality. Multivariate analysis revealed grades 3 and 4 HE [odds ratio (OR 32.1)], hyponatraemia (OR 9.2) and renal failure (OR 16.8) as significant predictors of 3-month mortality and a prognostic model using these predictors was constructed. Areas under the curve for the present predicted prognostic model, MELD, and CTP were 0.952, 0.941 and 0.636 respectively. CONCLUSIONS: ACLF due to hepatitis A or E super infection results in significant short-term mortality. The predictors of ominous outcome include grades 3 and 4 encephalopathy, hyponatraemia and renal failure. Present prognostic model and MELD scoring system were better predictors of 3-month outcome than CTP score in these patients. Early recognition of those with dismal prognosis may permit timely use of liver replacement/supportive therapies.
机译:背景和目的:急性甲型和戊型肝炎被认为是肝硬化患者,尤其是印度次大陆的肝功能失代偿的诱因。但是,由此引起的慢性慢性肝功能衰竭(ACLF)尚未得到很好的表征,尚无大量研究可用。我们的研究旨在评估具有这种独特形式肝衰竭的患者的临床概况和3个月死亡率的预测指标。方法:ACLF被诊断为急性甲型或戊型肝炎[血清胆红素和/或丙氨酸氨基转移酶突然升高并伴有阳性免疫球蛋白M的抗甲型肝炎病毒(HAV)/抗戊型肝炎病毒(HEV)],并具有临床证据肝功能衰竭(严重腹水和/或肝性脑病)和临床,生化,内窥镜检查(食管静脉曲张大小至少为II级),超声检查(存在结节性不规则肝并有门体侧支)或肝硬化的组织学证据。评估临床和实验室资料,使用单因素和多因素逻辑回归确定3个月死亡率的预测指标,并建立预后模型。绘制接收者操作曲线以测量当前的预后模型,终末期肝病(MELD)评分和Child-Turcotte-Pugh(CTP)评分的模型。结果:2000年1月至2006年6月收治的3220名肝硬化患者(平均年龄36.3 +/- 18.0岁;男:女85:36)中有121名(3.75%)发生了ACLF。这是由于80例HEV引起的(61.1%) %),HAV分别为33(27.2%)和8(6.1%)。潜在的肝硬化是由HBV(37),酒精(17),Wilson病(8),HCV(5),自身免疫(6),Budd-Chiari综合征(2),血色素沉着病(2)引起的,并且在休息(42)。常见表现为黄疸(100%),腹水(78%)和肝性脑病(55%)。平均(SD)CTP评分为11.4 +/- 1.6,平均MELD评分为28.6 +/- 9.06。三个月死亡率为54(44.6%)。观察到的并发症为败血症42例(31.8%),肾衰竭45例(34%),自发性细菌性腹膜炎27例(20.5%),UGI出血15例(11%)和低钠血症50例(41.3%)。单因素分析显示,腹水,肝性脑病,肾衰竭,胃肠道出血,总胆红素,低钠血症和凝血病是死亡率的重要预测指标。多变量分析显示3级和4级HE [比值比(OR 32.1)],低钠血症(OR 9.2)和肾衰竭(OR 16.8)是3个月死亡率的重要预测指标,并建立了使用这些预测指标的预后模型。当前预测的预后模型,MELD和CTP的曲线下面积分别为0.952、0.941和0.636。结论:由于甲型或戊型肝炎的超级感染而导致的ACLF导致显着的短期死亡率。不祥预后的预测因素包括3级和4级脑病,低钠血症和肾衰竭。在这些患者中,目前的预后模型和MELD评分系统比CTP评分更好地预测了3个月预后。早期识别预后不良的患者可允许及时使用肝替代/支持疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号